Selective and effective anticancer agents: Synthesis, biological evaluation and structure-activity relationships of novel carbazole derivatives. 2021

Wenbo Huang, and Zilin Gao, and Zhigang Zhang, and Wei Fang, and Zuoqian Wang, and Zhongyi Wan, and Liqiao Shi, and Kaimei Wang, and Shaoyong Ke
National Biopesticide Engineering Research Centre, Hubei Biopesticide Engineering Research Centre, Hubei Academy of Agricultural Sciences, Wuhan 430064, China.

Carbazole alkaloids is an important class of natural products with diverse biological functions. So, the aim of this article is to explore new chemical entities containing carbazole scaffold as potential novel cytotoxic agents based on our developed three-component indole-to-carbazole reaction. Two series of carbazole derivatives were designed and synthesized, and their in vitro cytotoxic activities against three cell lines (A875, HepG2, and MARC145) were evaluated. The results indicated that some of these carbazole derivatives exhibited significantly good cytotoxic activities against tested cell lines compared with the control 5-fluorouracil (5-FU). Especially, carbazole acylhydrazone compounds 7g and 7p displayed high inhibitory activity on cancer cells, but almost no activity on normal cells. Further analysis of induced apoptosis for potential compounds indicated that the potential antitumor agents induced cell death in A875 cells at least partly (initially) by apoptosis, which might be used as promising lead scaffold for discovery of novel carbazole-type cytotoxic agents.

UI MeSH Term Description Entries
D002227 Carbazoles Benzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Wenbo Huang, and Zilin Gao, and Zhigang Zhang, and Wei Fang, and Zuoqian Wang, and Zhongyi Wan, and Liqiao Shi, and Kaimei Wang, and Shaoyong Ke
April 1985, Journal of medicinal chemistry,
Wenbo Huang, and Zilin Gao, and Zhigang Zhang, and Wei Fang, and Zuoqian Wang, and Zhongyi Wan, and Liqiao Shi, and Kaimei Wang, and Shaoyong Ke
March 2011, European journal of medicinal chemistry,
Wenbo Huang, and Zilin Gao, and Zhigang Zhang, and Wei Fang, and Zuoqian Wang, and Zhongyi Wan, and Liqiao Shi, and Kaimei Wang, and Shaoyong Ke
November 2016, Chemical biology & drug design,
Wenbo Huang, and Zilin Gao, and Zhigang Zhang, and Wei Fang, and Zuoqian Wang, and Zhongyi Wan, and Liqiao Shi, and Kaimei Wang, and Shaoyong Ke
June 2008, Journal of medicinal chemistry,
Wenbo Huang, and Zilin Gao, and Zhigang Zhang, and Wei Fang, and Zuoqian Wang, and Zhongyi Wan, and Liqiao Shi, and Kaimei Wang, and Shaoyong Ke
May 2012, Bioorganic & medicinal chemistry,
Wenbo Huang, and Zilin Gao, and Zhigang Zhang, and Wei Fang, and Zuoqian Wang, and Zhongyi Wan, and Liqiao Shi, and Kaimei Wang, and Shaoyong Ke
March 2010, Oncology letters,
Wenbo Huang, and Zilin Gao, and Zhigang Zhang, and Wei Fang, and Zuoqian Wang, and Zhongyi Wan, and Liqiao Shi, and Kaimei Wang, and Shaoyong Ke
August 2013, Drug discoveries & therapeutics,
Wenbo Huang, and Zilin Gao, and Zhigang Zhang, and Wei Fang, and Zuoqian Wang, and Zhongyi Wan, and Liqiao Shi, and Kaimei Wang, and Shaoyong Ke
March 2009, Journal of medicinal chemistry,
Wenbo Huang, and Zilin Gao, and Zhigang Zhang, and Wei Fang, and Zuoqian Wang, and Zhongyi Wan, and Liqiao Shi, and Kaimei Wang, and Shaoyong Ke
July 2014, European journal of medicinal chemistry,
Wenbo Huang, and Zilin Gao, and Zhigang Zhang, and Wei Fang, and Zuoqian Wang, and Zhongyi Wan, and Liqiao Shi, and Kaimei Wang, and Shaoyong Ke
October 2015, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!